US2019133686A1PendingUtilityA1
Method of administering electromagnetic energy and compositions in the treatment of skin conditions
Est. expiryMar 15, 2033(~6.7 yrs left)· nominal 20-yr term from priority
A61M 35/00A45D 34/04A61B 2018/0047A61B 2018/2035A61B 18/1815A61B 2018/00476A61B 2018/00017A61B 2017/00756A61B 2018/2023A61B 18/203A45D 26/00A61N 2005/0659A61N 2005/0644A45D 2026/009A61N 2005/067A61N 5/067
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a laser system and laser handpiece and process for skin treatment. The system includes components for producing a continuous or pulse laser beam, and components for delivering a substance to the damaged region of skin. The system is designed to control and utilize the laser beam for damaging small volume of skin tissue and using a disposable tip to deliver a substance which is applied simultaneously or with some delay producing a combination of laser action with the action of a named substance at the same time.
Claims
exact text as granted — not AI-modified1 . A method for treating a skin condition, the method comprising:
a) providing a device configured to simultaneously administer electromagnetic energy and a composition to the skin; b) activating said device to simultaneously apply electromagnetic energy and a composition to the skin of a patient in need of treatment for a skin condition, wherein said activating treats said skin condition.
2 . The method of claim 1 , wherein said device comprises a tip configured to detachably connect to said handpiece, wherein said tip comprises a plurality of applicators, wherein each applicator comprises (i) a reservoir configured to contain said composition, and (ii) an opening.
3 . The method of claim 1 , wherein said device is configured to deliver electromagnetic energy selected from the group consisting of laser energy, microwave energy, radio frequency energy, electroporating energy, light emitting diode energy, and non-coherent light energy.
4 . The method of claim 1 , wherein said device is configured to deliver continuous laser energy or pulse laser beam energy.
5 . The method of claim 1 , wherein said device is configured to deliver laser energy at a wavelength selected from the group consisting of 532 nM, 540 nM, 980 nM, 1,064 nM, 1,440 nM, 1,550 nM, 1,930 nM, 2,790 nM, 2,940 nM, and 10,600 nM.
6 . The method of claim 1 , wherein said device is configured to (i) deliver laser energy, and (ii) comprises beam-shaping lenses configured to focus said laser energy on the skin of said patient when said applicators are in contact with the skin of said patient.
7 . The method of claim 1 , wherein said composition is selected from the group consisting of a suspension, a solution, a cream, a gel, and combinations thereof.
8 . The method of claim 1 , wherein said composition is selected from the group consisting of a medication, skin care product, anesthetic, vitamin, antioxidant, stem cell factor, stem cell, ointment, growth factor, dye, fibroblast, botox, drug, antibody, hyaluronic acid, black ointment, and cosmetic.
9 . The method of claim 1 , wherein said skin condition is selected from the group consisting of skin aging, scarring, acne, hair removal, hair growth, rhytides, wrinkles, telangiatesia, pigmented lesions, and tattoo removal.
10 . The method of claim 1 , wherein said skin condition is hair removal and said device comprises a Nd:YAG laser and said activating applies laser energy at a wavelength of 1064 nm.
11 . The method of claim 10 , wherein said composition comprises a black ointment.
12 . The method of claim 1 , wherein said skin condition is hair growth and said device is configured to deliver laser energy at a wavelength of 1930 nm, 2790 nm, 2940 nm, or 10600 nm.
13 . The method of claim 12 , wherein said composition is selected from the group consisting of stem cells, stem growth factors, and medication.
14 . The method of claim 1 , wherein said skin condition is selected from the group consisting of rhytides, scars, or wrinkles, and said device is configured to deliver laser energy at a wavelength of 980 nm, 1440 nm, or 1930 nm.
15 . The method of claim 14 , wherein said composition is selected from the group consisting of botox, fibroblasts, a filler, and stem cell factors.
16 . The method of claim 1 , wherein said skin condition is telangiatesia or pigmented lesions, and said device is configured to deliver laser energy at a wavelength of 980 nm, 532 nm, or 540 nm.
17 . The method of claim 16 , wherein said skin condition is telangiatesia and said composition is selected from the group consisting of Avastin, Lucentis, and an anti-angiogenic antibody.
18 . The method of claim 1 , wherein said skin condition is pigmented lesions and said device is configured to deliver laser energy at a wavelength of 980 nm, 532 nm, or 1440 nm.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.